A new pharmacologic agent, possible to be used in reducing insulin resistance.

Insulin resistance is the cornerstone of multiple diseases such as metabolic syndrome, diabetes mellitus, arterial hypertension, dyslipidemia, acute coronary syndrome, etc. There are some medications and changes in lifestyle that can reduce insulin resistance. Not all are suitable for all patients. We discovered another pharmacologic agent that can be successfully added to the old methods already in use.